BusinessVoyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s DiseaseBy Nasdaq OMXDec 7, 2016, 9:05 PM UTC
BusinessNeuroDerm to Host Fourth Quarter and 2015 Fiscal Year Financial Results Conference Call on March 31, 2016By Nasdaq OMXMar 22, 2016, 11:00 AM UTC
